Plasma Lipidomic Profiling Reveals Predictive Biomarkers and Pathogenic Pathways in Recurrent Ischemic Stroke
This study utilizes plasma lipidomics to identify specific lipid biomarkers, particularly LysoPC(16:0) and a four-lipid panel, which effectively predict recurrent ischemic stroke risk and reveal dysregulated glycerophospholipid and fatty acid metabolic pathways underlying the disease.